N/A
N=40
Minimally Invasive Surgery of the Hip Versus Standard Approach
Hip Arthroplasty · Osteoarthritis
Bottom Line
View on ClinicalTrials.gov: NCT00261040 ↗Enrolled (actual)
40
Serious AEs
5.0%
Results posted
Mar 2020
Primary outcome: Primary: Clinical Outcomes — 5.39; 5.74 Days
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Minimally Invasive Surgery (Procedure); Standard Surgery (Procedure)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Ottawa Hospital Research Institute
- Primary completion
- Dec 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Clinical Outcomes |
5.39; 5.74 | — |
| SECONDARY Harris Hip Score |
90.4031; 90.3011 | — |
| SECONDARY Change in Timed Get-up-and-Go Test (TUG) |
11.01; 12.03 | — |
| SECONDARY Operating Time Duration |
95.20; 87.70 | — |
| SECONDARY Estimated Blood Loss |
460; 462.50 | — |
Summary
The purpose of this study is to determine if there is a difference in terms of length of hospital stay and post-operative outcomes between patients whose total hip replacement surgery is performed with a minimally invasive versus standard surgical approach.
Eligibility Criteria
Inclusion Criteria
BMI > 30 kg/m2 No prior ipsilateral hip surgery Osteoarthritis
Exclusion Criteria
Patients with grossly distorted bony anatomy whereby standard implants are contraindicated; i.e. congenital dysplasia of the hip, proximal femoral abnormalities, etc
Rheumatoid Arthritis
Data sourced from ClinicalTrials.gov (NCT00261040). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.